1. Home
  2. VERA vs HTGC Comparison

VERA vs HTGC Comparison

Compare VERA & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$33.93

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

HOLD

Current Price

$15.40

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
HTGC
Founded
2016
2003
Country
United States
United States
Employees
N/A
50
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VERA
HTGC
Price
$33.93
$15.40
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$81.30
$18.86
AVG Volume (30 Days)
969.5K
1.8M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
12.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.18
Revenue Next Year
$472.48
$5.24
P/E Ratio
N/A
$8.61
Revenue Growth
N/A
N/A
52 Week Low
$18.76
$13.70
52 Week High
$56.05
$19.67

Technical Indicators

Market Signals
Indicator
VERA
HTGC
Relative Strength Index (RSI) 39.09 43.99
Support Level $34.04 $15.24
Resistance Level $42.77 $16.08
Average True Range (ATR) 1.94 0.36
MACD -0.15 -0.11
Stochastic Oscillator 17.80 9.46

Price Performance

Historical Comparison
VERA
HTGC

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

Share on Social Networks: